| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Enterococcus faecalis (high-level aminoglycoside-resistant) |
>2000 |
>2000 |
≤1000 － >2000 |
Streptomycin  |
123 |
| Enterococcus faecalis (HLGR + ESBL) |
1 |
1 |
1 － ? |
Levofloxacin (Levaquin, Quixin) |
117 |
| Enterococcus faecalis (HLGR) |
0.5 |
32 |
0.25 － 32 |
Sparfloxacin (AT-4140, Zagam) |
117 |
| Enterococcus faecalis (HLGR) |
1 |
32 |
0.5 － 32 |
Levofloxacin (Levaquin, Quixin) |
117 |
| Enterococcus faecalis (HLGR) |
1 |
64 |
1 － 64 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
117 |
| Enterococcus faecalis (HLGR) |
2 |
64 |
1 － 128 |
Ofloxacin (Floxin) |
117 |
| Enterococcus faecalis (HLGR) |
>128 |
>128 |
128 － >128 |
D-ofloxacin |
117 |
| Enterococcus faecalis (IFO 12580) |
- |
- |
25 － ? |
FNQ13 |
257 |
| Enterococcus faecalis (IFO 12580) |
- |
- |
>128 － ? |
Metronidazole (Flagyl) |
105 |
| Enterococcus faecalis (IFO 3989) |
- |
- |
2 － ? |
Bakuchiol |
100 |
| Enterococcus faecalis (IFO 3989) |
- |
- |
2 － ? |
Bakuchiol |
1462 |
| Enterococcus faecalis (IFO 3989) |
- |
- |
6 － ? |
Licochalcone A |
184 |
| Enterococcus faecalis (JCM 5803) |
- |
- |
6400 － ? |
Catechin |
1212 |
| Enterococcus faecalis (JH2-2 + glycopepitde-susceptible) |
- |
- |
1 － ? |
Teicoplanin (Targocid) |
167 |
| Enterococcus faecalis (JH2-2 + glycopeptide-susceptible) |
- |
- |
0.06 － ? |
Tigecycline (GAR-936, Tigacyl) |
199 |
| Enterococcus faecalis (JH2-2 + glycopeptide-susceptible) |
- |
- |
0.12 － ? |
Minocycline (Minocycline hydrochloride, Minocin) |
199 |
| Enterococcus faecalis (JH2-2 + glycopeptide-susceptible) |
- |
- |
0.25 － ? |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
199 |
| Enterococcus faecalis (JH2-2 + glycopeptide-susceptible) |
- |
- |
0.25 － ? |
Oritavancin (LY333328) |
167 |
| Enterococcus faecalis (JH2-2 + glycopeptide-susceptible) |
- |
- |
0.5 － ? |
Tetracycline (Sumycin, Achromycin V, Steclin) |
199 |
| Enterococcus faecalis (JH2-2 + glycopeptide-susceptible) |
- |
- |
1 － ? |
Teicoplanin (Targocid) |
167 |
| Enterococcus faecalis (JH2-2 + glycopeptide-susceptible) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
199 |
| Enterococcus faecalis (JH2-2 + glycopeptide-susceptible) |
- |
- |
2 － ? |
Oritavancin (LY333328) |
167 |
| Enterococcus faecalis (JH2-2 + glycopeptide-susceptible) |
- |
- |
2 － ? |
Teicoplanin (Targocid) |
199 |
| Enterococcus faecalis (JH2-2 + glycopeptide-susceptible) |
- |
- |
2 － ? |
Vancomycin (Vancocyn, Lyphocin) |
167 |
| Enterococcus faecalis (JH2-2 + glycopeptide-susceptible) |
- |
- |
2 － ? |
Vancomycin (Vancocyn, Lyphocin) |
167 |
| Enterococcus faecalis (JH2-2) |
- |
- |
1 － ? |
Teicoplanin (Targocid) |
210 |
| Enterococcus faecalis (JH2-2) |
- |
- |
1 － ? |
Teicoplanin (Targocid) |
449 |
| Enterococcus faecalis (JH2-2) |
- |
- |
2 － ? |
Oritavancin (LY333328) |
449 |